Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Every Certificate of Analysis we've ingested from hydroresearchpeptides.com, what each tests for, and what's missing. Sourced back to the original COA URLs — no hosting, no editorial.
Each row is one peptide. Columns show whether at least one COA from this vendor for that peptide tests for that property. Endotoxin and sterility are usually the gap.
| Peptide | COAs | Avg purity | HPLC | MS/MALDI | NMR | Endotoxin | Sterility | Metals | Microbial |
|---|---|---|---|---|---|---|---|---|---|
| 5-Amino-1 MQ | 1 | — | — | — | — | — | — | ||
| AOD-9604 |
Most recent batches we've ingested. Each row links to the original COA file as published by the vendor.
How this is built: we discover every COA URL on the vendor's public testing page, fetch the file, run structured extraction, and persist what each COA actually tests for. Vendor copy isn't a signal — only the COAs themselves.
Full methodology →| 1 |
| 99.11% |
| — |
| — |
| — |
| — |
| BPC-157 | 6 | 99.33% | — | — |
| Cagri/Reta Blend | 2 | 99.99% | — | — |
| Cagrilintide + Semaglutide | 1 | 99.91% | — | — | — |
| CJC/IPA | 1 | — | — | — | — |
| DSIP | 1 | 99.86% | — | — |
| Epithalon | 1 | 99.60% | — | — |
| GHK-Cu | 2 | 99.66% | — | — | — | — |
| GLOW (TB500 + BPC157 + GHK-CU) | 1 | — | — | — | — | — | — |
| IGF-1 (Insulin-like Growth Factor 1) | 1 | — | — | — | — |
| IGF-1 LR3 | 1 | 99.52% | — | — | — | — |
| KLOW 80 | 2 | — | — | — | — | — |
| KPV | 1 | 99.75% | — | — | — | — |
| L-Glutathione | 1 | 99.21% | — | — | — | — |
| Lipo-B | 2 | — | — | — | — | — |
| Lipo-C | 3 | — | — | — | — |
| Mazdutide | 2 | 99.57% | — |
| Melanotan 1 | 1 | 99.60% | — | — | — | — |
| Melanotan II | 1 | 99.45% | — | — | — | — |
| MOTS-C | 1 | 99.93% | — | — | — | — |
| NAD+ | 1 | — | — | — | — |
| PT-141 | 1 | 99.93% | — | — | — |
| R20 | 3 | — | — | — | — |
| R40 | 3 | — | — | — | — |
| Retatrutide | 8 | 99.68% | — | — |
| Selank | 1 | 99.04% | — | — | — | — |
| Semaglutide | 3 | 99.48% | — | — |
| Snap-8 | 2 | 99.73% | — |
| SS-31 | 1 | 99.92% | — | — | — |
| Survodutide | 2 | 99.66% | — |
| T15 | 3 | — | — | — | — |
| T30 | 3 | — | — | — | — |
| T60 | 1 | — | — | — | — | — | — | — |
| TB-500 | 2 | 99.54% | — | — | — |
| Tesamorelin | 2 | 99.24% | — | — |
| Thymosin Alpha-1 | 1 | 99.16% | — | — | — | — |
| Tirzepatide | 7 | 99.79% | — | — |
| Tesamorelin |
| HYDROXA9KS7Z |
| Janoshik Analytical |
| 99.24% |
| — |
| 2025-12-08 |
| View |
| Tirzepatide | HYDROV4N8C1Z | Janoshik Analytical | — | LAL | 2025-12-05 | View |
| 5-Amino-1 MQ | HYDROB7SHKSU | Janoshik Analytical | — | — | 2025-11-21 | View |
| TB-500 | HYDRO3L6MDGQ | Janoshik Analytical | 99.35% | — | 2025-11-20 | View |
| GHK-Cu | HYDROD7PH63M | Janoshik Analytical | 99.66% | — | 2025-11-20 | View |
| Melanotan II | HYDRO11WN68L | Janoshik Analytical | 99.45% | — | 2025-11-20 | View |
| L-Glutathione | HYDROJ9Y2WD6 | Janoshik Analytical | 99.21% | — | 2025-11-20 | View |
| KLOW 80 | HYDRO48KA5F1 | Janoshik Analytical | — | — | 2025-11-20 | View |
| Selank | HYDROH2P9X6D | Janoshik Analytical | 99.04% | — | 2025-11-20 | View |
| Melanotan 1 | HYDROCP7QHN3 | Janoshik Analytical | 99.60% | — | 2025-11-20 | View |
| Thymosin Alpha-1 | HYDR06S1HTG1 | Janoshik Analytical | 99.16% | — | 2025-11-20 | View |
| BPC-157 | HYDRO9B4C1MC | Janoshik Analytical | 99.07% | — | 2025-11-20 | View |
| KPV | HYDROBZ3UK38 | Janoshik Analytical | 99.75% | — | 2025-11-20 | View |
| BPC-157 | HYDRO Q5L7R8S | Janoshik Analytical | 99.60% | — | 2025-11-20 | View |
| CJC/IPA | HYD-CJCIPA-2508-01 | Janoshik Analytical | — | LALHM | 2025-09-02 | View |
| IGF-1 (Insulin-like Growth Factor 1) | HYD-IGFLR3-2508-02 | Janoshik Analytical | — | LALHM | 2025-09-02 | View |
| IGF-1 LR3 | HYD-IGFLR3-2508-02 | Janoshik Analytical | 99.52% | — | 2025-08-15 | View |
| T15 | HY-T15-K1X30 | Janoshik Analytical | — | — | 2025-08-13 | View |
| R20 | HY-R20-72975 | Janoshik Analytical | — | — | 2025-08-13 | View |
| T30 | HY-T30-RXJ0725 | Janoshik Analytical | — | — | 2025-08-13 | View |
| R40 | HY-R40-MN0724 | Janoshik Analytical | — | — | 2025-08-13 | View |
| T30 | HY-T30-RXJ0725 | Janoshik Analytical | — | LAL | 2025-08-05 | View |
| R20 | HY-R20-72975 | Janoshik Analytical | — | LAL | 2025-08-05 | View |
| T15 | HY-T15-K1X30 | Janoshik Analytical | — | LAL | 2025-08-05 | View |
| R40 | HY-R40-MN0724 | Janoshik Analytical | — | LAL | 2025-08-05 | View |
| T15 | HY-T15-K1X30 | Janoshik Analytical | — | HM | 2025-07-30 | View |
| R20 | HY-R20-72975 | Janoshik Analytical | — | HM | 2025-07-30 | View |
| T60 | HY-T60-0801B | Janoshik Analytical | — | HM | 2025-07-30 | View |
| T30 | AD-T30-29JUL5 | Janoshik Analytical | — | HM | 2025-07-30 | View |
| Tirzepatide | HY-T60-0801B | Janoshik Analytical | 99.91% | — | 2025-07-30 | View |
| Retatrutide | HY-R40-MN0724 | Janoshik Analytical | 99.83% | — | 2025-07-30 | View |
| Tirzepatide | HY-T15-K1X30 | Janoshik Analytical | 99.87% | — | 2025-07-30 | View |
| R40 | HY-R40-MN0724 | Janoshik Analytical | — | HM | 2025-07-30 | View |
| Tirzepatide | HY-T30-RXJ0725 | Janoshik Analytical | 99.90% | — | 2025-07-30 | View |
| Tirzepatide | HRP-TZP-K94VMQ | Janoshik Analytical | 99.69% | LALHM | 2025-07-15 | View |
| KLOW | KLOW | Janoshik Analytical | — | LALHM | 2025-06-20 | View |
| NAD+ | ND-R94KX2 | Janoshik Analytical | — | LALHM | 2025-05-12 | View |
| Cagri/Reta Blend | crb-H90X | Janoshik Analytical | — | LALHM | 2025-05-12 | View |
| DSIP | DS-Z29TRQ | Janoshik Analytical | 99.86% | LALHM | 2025-04-28 | View |
| Epithalon | EP-YT34L1 | Janoshik Analytical | 99.60% | LALHM | 2025-04-28 | View |
| Retatrutide | reta10-H22W | Janoshik Analytical | 99.29% | HM | 2025-04-28 | View |
| GLOW (TB500 + BPC157 + GHK-CU) | glow-H21B | Janoshik Analytical | — | — | 2025-04-02 | View |
| Retatrutide | RET15-002 | Janoshik Analytical | 99.78% | HM | 2025-03-18 | View |
| Semaglutide | SEM10-002 | Janoshik Analytical | 99.81% | LALHM | 2025-03-18 | View |
| Semaglutide | SEM5-002 | Janoshik Analytical | 99.15% | LALHM | 2025-03-18 | View |
| Retatrutide | RET15-003 | Janoshik Analytical | — | LAL | 2024-10-11 | View |
| SS-31 | SS31-003 | Janoshik Analytical | 99.92% | LALHM | 2024-10-04 | View |
Disclosed Labs